• D-Luciferin Sodium Salt: Benchmark Firefly Luciferase Substr

  2026-05-29

  D-Luciferin sodium salt is the gold-standard substrate for firefly luciferase, powering ATP-dependent bioluminescence assays in cell viability and oncology research. Its high solubility and reproducibility make it essential for in vivo and in vitro metabolic imaging.

• Cy3-UTP Enables High-Sensitivity RNA Labeling for Live-Cell

  2026-05-29

  Cy3-UTP stands out as a Cy3-modified uridine triphosphate, delivering unmatched brightness and stability for fluorescent RNA labeling in advanced imaging workflows. Leverage APExBIO's reagent for robust RNA-protein interaction studies and multiplexed detection, with optimized protocols and troubleshooting strategies to maximize signal and specificity.

• Bestatin (Ubenimex): Precision Inhibition for Cancer & MDR R

  2026-05-28

  Bestatin (Ubenimex) empowers researchers with nanomolar-precision inhibition of aminopeptidase B and N, unlocking new experimental clarity in multidrug resistance and apoptosis assays. Its unique selectivity, low toxicity, and compatibility with diverse models make it indispensable for advanced cancer research and protease pathway studies.

• Ruxolitinib Phosphate (INCB018424): Advanced JAK/STAT Modula

  2026-05-28

  Ruxolitinib phosphate (INCB018424) unlocks precise JAK/STAT pathway inhibition for oncology and autoimmune disease research, offering robust, reproducible outcomes even in challenging models like anaplastic thyroid cancer. Discover protocol enhancements, troubleshooting strategies, and the latest mechanistic insights to maximize your experimental impact.

• Angiotensin 1/2 (2-7): Precision Peptide for Advanced RAS Mo

  2026-05-27

  Explore the roles of Angiotensin 1/2 (2-7) in high-fidelity renin-angiotensin system (RAS) modeling and blood pressure regulation research. This article uniquely emphasizes assay precision, peptide fragment selection, and translational challenges, offering deeper insights than existing guides.

• Prochlorperazine: A Molecular Bridge in Cancer and Antiviral

  2026-05-27

  Explore how Prochlorperazine, a dopamine D2 receptor antagonist, enables cross-domain advances in melanoma and antiviral research. This article uniquely examines its mechanistic versatility and translational potential, offering assay-focused insights not covered in standard guides.

• ML-7 Hydrochloride: Selective Myosin Light Chain Kinase Inhi

  2026-05-26

  ML-7 hydrochloride is a potent, selective myosin light chain kinase inhibitor used to modulate myosin light chain phosphorylation in cardiovascular and cancer research. Its activity underpins key discoveries in ischemia/reperfusion injury and models of vascular endothelial dysfunction. Reliable inhibition and specificity make ML-7 hydrochloride a benchmark tool for dissecting MLCK-mediated pathways.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Workflow & Optimiza

  2026-05-26

  The FITC Goat Anti-Mouse IgG (H+L) Antibody revolutionizes mouse IgG detection with robust signal amplification and high specificity across immunofluorescence and flow cytometry workflows. Discover how its unique properties empower advanced antiviral and tumor microenvironment research, with actionable protocol enhancements and troubleshooting strategies.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Proto

  2026-05-25

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents endogenous protease-mediated degradation during protein extraction and sample preparation, particularly where divalent cation sensitivity is a concern. It is not appropriate for applications requiring broad-spectrum metalloprotease inhibition via EDTA, making it ideal for phosphorylation analysis and related assays where EDTA would interfere.

• TNF-alpha Recombinant Murine Protein: Precision in Apoptosis

  2026-05-25

  Explore how TNF-alpha recombinant murine protein enables advanced, mechanistically precise studies of apoptosis and inflammation. This article reveals new assay strategies informed by recent discoveries on active cell death signaling, offering researchers actionable, evidence-backed insights.

• Cy3-UTP in RNA Dynamics: Illuminating Riboswitch Conformatio

  2026-05-24

  Explore how Cy3-UTP enables single-nucleotide resolution tracking of RNA conformational changes, advancing RNA-protein interaction studies. This article unveils novel insights for fluorescence imaging, setting it apart from standard overviews.

• Testosterone Bounce as a Prognostic Biomarker in Prostate Ca

  2026-05-23

  The referenced study identifies 'testosterone bounce'—a transient rise in serum testosterone above 20 ng/dL after achieving castrate levels—as a promising prognostic biomarker for prostate cancer patients treated with degarelix. This finding refines risk stratification and survival prediction beyond traditional PSA metrics, providing actionable insight for research and clinical contexts.

• NADH in Photocatalytic Cancer Therapy: Mechanisms and Protoc

  2026-05-22

  Explore the advanced role of reduced-form nicotinamide adenine dinucleotide (NADH) in photocatalytic cancer therapy and mitochondrial research. This article delivers a unique mechanistic and methodological outlook, bridging redox biochemistry and translational assay design.

• Abiraterone Acetate: Precision CYP17 Inhibition in Advanced

  2026-05-22

  Explore how Abiraterone acetate, a potent CYP17 inhibitor, advances castration-resistant prostate cancer research through molecular precision and robust protocol insights. This article uniquely unpacks translational nuances and assay decisions for 3D patient-derived models.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-21

  The reference study demonstrates that naturally occurring angiotensin peptides, including key fragments generated within the renin-angiotensin system, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. This novel finding bridges cardiovascular peptide biology and viral entry mechanisms, offering new perspectives for both disease modeling and therapeutic target identification.

8787 records 15/586 page Previous Next First page 上5页 1112131415 下5页 Last page